Reviva Pharmaceuticals Holdings (RVPH) Earnings Date & Reports
A.I. Advisor
published Earnings
RVPH is expected to report earnings to fall 10.77% to -23 cents per share on November 11
Q3'24
Est.
$-0.23
Q2'24
Beat
by $0.04
Q1'24
Beat
by $0.13
Q4'23
Missed
by $0.03
Q3'23
Missed
by $0.08
The last earnings report on August 15 showed earnings per share of -25 cents, beating the estimate of -30 cents. With 271.22K shares outstanding, the current market capitalization sits at 42.03M.
a blank check company, which focuses on the merger, capital stock exchange, asset acquisition, stock purchase, reorganization, recapitalization, and exchangeable share transaction.